Ramucirumab Intravenous and Von willebrand factor recombinant Intravenous
Determining the interaction of Ramucirumab Intravenous and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ramucirumab Intravenous-Vonvendi
- Ramucirumab Intravenous-Vopac
- Ramucirumab Intravenous-Vopac MDS
- Ramucirumab Intravenous-Vorapaxar
- Ramucirumab Intravenous-Vorapaxar Sulfate
- Ramucirumab Intravenous-Voraxaze
- Von willebrand factor recombinant Intravenous-Ranexa
- Von willebrand factor recombinant Intravenous-Ranibizumab
- Von willebrand factor recombinant Intravenous-Ranibizumab Intraocular
- Von willebrand factor recombinant Intravenous-Ranibizumab ophthalmic
- Von willebrand factor recombinant Intravenous-Ranitidine
- Von willebrand factor recombinant Intravenous-Ranitidine Capsule